---
title: "RVPH.US (RVPH.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/RVPH.US/news.md"
symbol: "RVPH.US"
name: "RVPH.US"
parent: "https://longbridge.com/en/quote/RVPH.US.md"
datetime: "2026-05-20T05:45:20.284Z"
locales:
  - [en](https://longbridge.com/en/quote/RVPH.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/RVPH.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/RVPH.US/news.md)
---

# RVPH.US (RVPH.US) — Related News

### [Reviva Pharmaceuticals | 8-K: FY2026 Q1 Revenue: USD 0](https://longbridge.com/en/news/286315254.md)
*2026-05-13T20:44:51.000Z*
### [12 Health Care Stocks Moving In Wednesday's Intraday Session](https://longbridge.com/en/news/286296422.md)
*2026-05-13T17:06:16.000Z*
> In Wednesday's intraday session, Quantum Cyber (NASDAQ:QUCY) saw a significant gain of 163.0%, reaching $0.85, while Whi

### [Reviva Reports First Quarter 2026 Financial Results and Recent Business Highlights | RVPH Stock News](https://longbridge.com/en/news/286313938.md)
*2026-05-13T12:35:35.000Z*
> Reviva Reports First Quarter 2026 Financial Results and Recent Business Highlights | RVPH Stock News

### [](https://longbridge.com/en/news/283225675.md)
*2026-04-18T13:29:53.000Z*
> FDA Commissioner Robert Califf: The FDA is accelerating the voucher application process for 5-hydroxytryptamine 2A agoni

### [](https://longbridge.com/en/news/281044529.md)
*2026-03-30T14:45:03.000Z*
> Reviva Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q4 EPS results.

### [Reviva Reports Full Year 2025 Financial Results and Recent Business Highlights | RVPH Stock News](https://longbridge.com/en/news/280996019.md)
*2026-03-30T02:05:34.000Z*
> Reviva Reports Full Year 2025 Financial Results and Recent Business Highlights | RVPH Stock News

### [Reviva Pharmaceuticals | 8-K: FY2025 Revenue: USD 0](https://longbridge.com/en/news/280997365.md)
*2026-03-30T10:13:39.000Z*